Revolution Medicines, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
29.56
|
|
Average Rating
|
4.20
|
|
# Strong Buys
|
5
|
|
# Buys
|
2
|
|
# Holds
|
3
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.84
|
-0.87
|
-0.03
|
-3.57%
|
|
2022-06-30
|
-0.85
|
-0.82
|
0.03
|
3.53%
|
|
2022-03-31
|
-0.77
|
-0.78
|
-0.01
|
-1.30%
|
|
2021-12-31
|
-0.64
|
-0.71
|
-0.07
|
-10.94%
|
|
2021-09-30
|
-0.62
|
-0.72
|
-0.10
|
-16.13%
|
|
2021-06-30
|
-0.56
|
-0.60
|
-0.04
|
-7.14%
|
|
2021-03-31
|
-0.52
|
-0.53
|
-0.01
|
-1.92%
|
|
2020-12-31
|
-0.38
|
-0.52
|
-0.14
|
-36.84%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-2.47
|
|
2021-12-31
|
-2.56
|
|
2020-12-31
|
-2.14
|
|
2019-12-31
|
-6.89
|